A Post-Marketing Observational Study to Evaluate Safety and Effectiveness of Upadacitinib in Adolescent Patients Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)
A Post-Marketing Observational Study to Evaluate Safety and Effectiveness of Upadacitinib in Adolescent Patients Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)
Atopic dermatitis (AD; also known as atopic eczema) is an inflammatory skin disease. The safety and effectiveness of upadacitinib for AD has been well-documented in previous studies, however, these studies included a limited number of adolescent patients in Japan. Therefore, the purpose of this observational study is to evaluate safety and effectiveness of upadacitinib in adolescent AD participants age 12 to <18 years old in Japan in the real-world setting.
Upadacitinib is an approved drug being developed for the treatment of AD in adolescents in Japan. Around 170 participants age 12 to <18 who are prescribed upadacitinib for the treatment of AD in routine clinical practice will be enrolled at multiple sites in Japan.
Participants will receive oral upadacitinib as prescribed by their physician. Data from these participants will be collected for approximately 2 years.
There will be no additional burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the course of the study at a hospital or clinic and will be asked to provide additional information by questionnaire at each visit.
Inclusion Criteria:
Exclusion Criteria:
Asahi Owari, Aichi-ken 488-0032, Japan
Ichinomiya-shi, Aichi-ken 491-8558, Japan
Obu-shi, Aichi-ken 474-8710, Japan
Inzai-shi, Chiba 270-1613, Japan
Yotsukaido-shi, Chiba 284-0003, Japan
Iizuka-shi, Fukuoka 820-8505, Japan
Kurume-shi, Fukuoka 830-0011, Japan
Koriyama-shi, Fukushima 963-8501, Japan
Minokamo-shi, Gifu 505-8510, Japan
Kitami-shi, Hokkaido 090-0026, Japan
Obihiro-Shi, Hokkaido 080-0013, Japan
Himeji-shi, Hyōgo 679-2151, Japan
Sichuan, Hyōgo 666-0017, Japan
Nonoichi-shi, Ishikawa-ken 921-8821, Japan
Hiratsuka-shi, Kanagawa 254-0065, Japan
Sagamihara-shi, Kanagawa 252-0392, Japan
Hirakata-shi, Osaka 573-1191, Japan
Sakai-shi, Osaka 599-8272, Japan
Takatsuki-shi, Osaka 569-8686, Japan
Kasukabe-shi, Saitama 344-0011, Japan
Nagahama-shi, Shiga 526-8585, Japan
Kakegawa-shi, Shizuoka 436-0040, Japan
Kakegawa-shi, Shizuoka 436-0040, Japan
Hachioji-shi, Tokyo 193-0998, Japan
Shibuya Ward, Tokyo 150-0013, Japan
Sumida-ku, Tokyo 130-8587, Japan
Tonami-shi, Toyama 939-1395, Japan
Hohu-shi, Yamaguchi 747-8511, Japan